Clinical characteristics at last follow-up visit
| Patients, n (%) | |
|---|---|
| Relapse | 17 (14.7) |
| once; twice; three times | 14 (12.1); 2 (1.7); 1 (0.9) |
| skin limited | 15 (12.9) |
| skin + renal; skin + GI | 1 (0.9);1 (0.9) |
| Urinary abnormalities | 42 (36.2) |
| microhematuria | 33 (28.4) |
| proteinuria – <1g/day; ≥1g/day | 10 (8.6); 5 (4.3) |
| Renal function worsening | 10 (8.6) |
| Treatment, # (%) | 107 (77.0) |
| local GC, # (%) | 9 (6.5) |
| systemic GC, # (%) | 98 (70.5) |
| cyclophosphamide, # (%) | 11 (7.9) |
| IVIG, # (%) | 4 (2.9) |
Legend: GC – glucocorticoids; IVIG – intravenous immunoglobulin.